Should Changes in Drug Price Over Time Be Considered in Cost-Effectiveness Analyses?

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1781
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Statins for Stroke Should Be Considered in Biologically Fit People Over 75

BMJ
2000English

NICE’s Cost-Effectiveness Range: Should It Be Lowered?

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
2014English

Effectiveness and Cost Effectiveness of Compression Bandages Should Be Shown

BMJ
1998English

Drug-Related Covariates Should Be Considered in Bayesian Network Meta-Analysis of Pharmacological Interventions

Hepatology
MedicineHepatology
2016English

How Much Tramadol Should Be Considered Lethal in Overdose?

Arhiv za Higijenu Rada i Toksikologiju
EnvironmentalPublic HealthToxicologyOccupational Health
2016English

Emergent Colorectal Surgery: What Should Be Considered?

Annals of Coloproctology
Gastroenterology
2016English

Cost-Effectiveness Analyses

1966English

Getting the Cost Right in Cost-Effectiveness Analyses

American Journal of Psychiatry
PsychiatryMental Health
1997English

The Security of People Should Be Considered First

Journal of Korean Medical Science
Medicine
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy